NO983829L - Nye substituerte N-metyl-N-(4-(4-(1H-benzimidazol-2-yl)[1,4]diazepan-1-yl)-2-(aryl)butyl)benzamider som er anvendbare for behandling av allergiske sykdommer - Google Patents
Nye substituerte N-metyl-N-(4-(4-(1H-benzimidazol-2-yl)[1,4]diazepan-1-yl)-2-(aryl)butyl)benzamider som er anvendbare for behandling av allergiske sykdommerInfo
- Publication number
- NO983829L NO983829L NO983829A NO983829A NO983829L NO 983829 L NO983829 L NO 983829L NO 983829 A NO983829 A NO 983829A NO 983829 A NO983829 A NO 983829A NO 983829 L NO983829 L NO 983829L
- Authority
- NO
- Norway
- Prior art keywords
- diazepan
- benzimidazol
- aryl
- butyl
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60459096A | 1996-02-21 | 1996-02-21 | |
| US78199797A | 1997-01-06 | 1997-01-06 | |
| PCT/US1997/001601 WO1997030991A1 (en) | 1996-02-21 | 1997-01-29 | Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl)[1,4]diazepan-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO983829D0 NO983829D0 (no) | 1998-08-20 |
| NO983829L true NO983829L (no) | 1998-10-20 |
Family
ID=27084698
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO983829A NO983829L (no) | 1996-02-21 | 1998-08-20 | Nye substituerte N-metyl-N-(4-(4-(1H-benzimidazol-2-yl)[1,4]diazepan-1-yl)-2-(aryl)butyl)benzamider som er anvendbare for behandling av allergiske sykdommer |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0888338B1 (no) |
| JP (1) | JP2000505083A (no) |
| KR (1) | KR19990087130A (no) |
| CN (1) | CN1143856C (no) |
| AR (1) | AR005897A1 (no) |
| AT (1) | ATE282609T1 (no) |
| AU (1) | AU708738B2 (no) |
| BR (1) | BR9710712A (no) |
| CA (1) | CA2246994C (no) |
| DE (1) | DE69731620D1 (no) |
| HU (1) | HUP9900401A3 (no) |
| IL (1) | IL125605A0 (no) |
| NO (1) | NO983829L (no) |
| NZ (1) | NZ330909A (no) |
| TW (1) | TW440565B (no) |
| WO (1) | WO1997030991A1 (no) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6194406B1 (en) | 1995-12-20 | 2001-02-27 | Aventis Pharmaceuticals Inc. | Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease |
| US6423704B2 (en) | 1995-12-20 | 2002-07-23 | Aventis Pharmaceuticals Inc. | Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases |
| US7030150B2 (en) * | 2001-05-11 | 2006-04-18 | Trimeris, Inc. | Benzimidazole compounds and antiviral uses thereof |
| EP2129381A1 (en) | 2007-01-24 | 2009-12-09 | Glaxo Group Limited | Pharmaceutical compositions comprising 3, 5-diamin0-6- (2, 3-dichl0phenyl) -l, 2, 4-triazine or r (-) -2, 4-diamino-5- (2, 3-dichlorophenyl) -6-fluoromethyl pyrimidine and an nk1 |
| CN112778279B (zh) * | 2021-01-25 | 2021-09-28 | 苏州正永生物医药有限公司 | 一种依美斯汀化合物的制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5879983A (ja) * | 1981-11-06 | 1983-05-13 | Kanebo Ltd | 新規なベンズイミダゾ−ル誘導体、その製造法およびその医薬組成物 |
| IL99320A (en) * | 1990-09-05 | 1995-07-31 | Sanofi Sa | Arylalkylamines, their preparation and pharmaceutical preparations containing them |
| GB9310713D0 (en) * | 1993-05-24 | 1993-07-07 | Zeneca Ltd | Aryl substituted heterocycles |
| MX9701305A (es) * | 1994-08-25 | 1998-05-31 | Merrell Pharma Inc | Piperidinas sustituidas novedosas utiles para el tratamiento de enfermedades alergicas. |
| US5607936A (en) * | 1994-09-30 | 1997-03-04 | Merck & Co., Inc. | Substituted aryl piperazines as neurokinin antagonists |
-
1997
- 1997-01-29 NZ NZ330909A patent/NZ330909A/en unknown
- 1997-01-29 WO PCT/US1997/001601 patent/WO1997030991A1/en active IP Right Grant
- 1997-01-29 KR KR1019980706521A patent/KR19990087130A/ko not_active Application Discontinuation
- 1997-01-29 CA CA002246994A patent/CA2246994C/en not_active Expired - Fee Related
- 1997-01-29 BR BR9710712A patent/BR9710712A/pt not_active IP Right Cessation
- 1997-01-29 DE DE69731620T patent/DE69731620D1/de not_active Expired - Lifetime
- 1997-01-29 AU AU22531/97A patent/AU708738B2/en not_active Ceased
- 1997-01-29 AT AT97905700T patent/ATE282609T1/de not_active IP Right Cessation
- 1997-01-29 CN CNB971923833A patent/CN1143856C/zh not_active Expired - Fee Related
- 1997-01-29 JP JP9530170A patent/JP2000505083A/ja not_active Abandoned
- 1997-01-29 HU HU9900401A patent/HUP9900401A3/hu unknown
- 1997-01-29 EP EP97905700A patent/EP0888338B1/en not_active Expired - Lifetime
- 1997-01-29 IL IL12560597A patent/IL125605A0/xx unknown
- 1997-02-18 TW TW086101884A patent/TW440565B/zh not_active IP Right Cessation
- 1997-02-19 AR ARP970100646A patent/AR005897A1/es not_active Application Discontinuation
-
1998
- 1998-08-20 NO NO983829A patent/NO983829L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TW440565B (en) | 2001-06-16 |
| HUP9900401A2 (hu) | 2000-03-28 |
| DE69731620D1 (de) | 2004-12-23 |
| EP0888338A1 (en) | 1999-01-07 |
| CN1211248A (zh) | 1999-03-17 |
| AU2253197A (en) | 1997-09-10 |
| NZ330909A (en) | 2001-04-27 |
| IL125605A0 (en) | 1999-03-12 |
| JP2000505083A (ja) | 2000-04-25 |
| CA2246994A1 (en) | 1997-08-28 |
| CN1143856C (zh) | 2004-03-31 |
| ATE282609T1 (de) | 2004-12-15 |
| NO983829D0 (no) | 1998-08-20 |
| HUP9900401A3 (en) | 2002-10-28 |
| AR005897A1 (es) | 1999-07-21 |
| CA2246994C (en) | 2002-04-30 |
| KR19990087130A (ko) | 1999-12-15 |
| BR9710712A (pt) | 1999-08-17 |
| AU708738B2 (en) | 1999-08-12 |
| EP0888338B1 (en) | 2004-11-17 |
| WO1997030991A1 (en) | 1997-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20021811D0 (no) | Nye oksabispidinforbindelser som er nyttige i behandlingen av hjertearrytmier | |
| HUP9900927A3 (en) | Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases | |
| FI972684A0 (fi) | Piperidiinietikkahappojohdannaisia, joita voidaan käyttää fibrinogeeniantagonisteina | |
| NO991459L (no) | Anvendelse av 1-hydroksy-2-pyridoner til behandling av hudinfeksjoner | |
| BR9612074A (pt) | Novos 4-(1h-benzimidazol-2-il)(1,4) diazepanos substituidos úteis para o tratamento de doenças alérgicas | |
| NO983829L (no) | Nye substituerte N-metyl-N-(4-(4-(1H-benzimidazol-2-yl)[1,4]diazepan-1-yl)-2-(aryl)butyl)benzamider som er anvendbare for behandling av allergiske sykdommer | |
| NO20012541D0 (no) | Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner | |
| HUP9901751A3 (en) | Novel substituted n-methyl-n-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases | |
| NO20005216D0 (no) | Sammensetning for behandling av eksterne sekresjonssykdommer unntatt hypolakrimasjon | |
| NO983830D0 (no) | Nye substituerte N-metyl-N-(4-(4-(1H-benzimidazol-2-yl-amino)piperidin-1-yl)-2-(aryl)butyl)benzamider som er anvendbare for behandling av allergiske sykdommer | |
| NO20012612D0 (no) | Isonipecotamider for behandling av integren-formidlede lidelser | |
| NO992968L (no) | Nye 4-(1-piperazinyl)benzosyrederivater, fremgangsmåte for fremstilling derav, samt deres terapeutiske anvendelser | |
| NO20012540D0 (no) | Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner | |
| ZA971321B (en) | Novel substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl)[1,4]diazepan-1-yl)-2-(aryl)butyl)benzamide useful for the treatment of allergic diseases. | |
| FR2731618B1 (fr) | Composition ophtalmique topique comprenant un derive de 2-(4-(azolylbutyl)-piperazinyl-methyl)-benzimidazole, notamment pour le traitement de la conjonctivite allergique | |
| NO20016127L (no) | Nye bisbidinforbindelser som er nyttige i behandlingen av hjertearytmier | |
| NO985558D0 (no) | Ny forbedret formulering for behandling av tromboembolisme | |
| FI990736A (fi) | Suoja- tai säilöntäainekoostumus, sen valmistusmenetelmä sekä sen käyttö | |
| SI0888336T1 (en) | Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl-amino)p iperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases | |
| NO20005856D0 (no) | Anvendelse av 1,1-diokso-perhydro-1,2,4-tiadiaziner | |
| HK1018956A1 (en) | Novel substituted n-methyl-n-(4-(piperidin-1-yl)-2-(aryl)butyl benzamides useful for the treatment of allergic diseases | |
| ZA971323B (en) | Novel substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl-amino)piperidin 1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases. | |
| HUP9903490A3 (en) | Substituted 4-(1h-benzimidazol-2-yl)[1,4]diazepanen derivatives useful for the treatment of allergic diseases, preparation and use thereof | |
| SI0874843T1 (en) | Substituted 4-(1h-benzimidazol-2-yl) 1,4)diazepanes useful for the treatment of allergic diseases | |
| ITRM920516A1 (it) | Composizione e suo uso per il trattamento terapeutico di affezioni dermatitiche, particolarmente la psoriasi. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |